Navigation Links
Vestaron Corporation Announces New Leadership

KALAMAZOO, Mich., April 28, 2011 /PRNewswire/ -- Vestaron Corporation, a Kalamazoo-based company developing the next- generation of environmentally conscious insecticide products, announced today that John Sorenson, Ph.D., will serve as interim President and Chief Executive Officer. The Board of Directors thanks John McIntyre for his years of service leading to the development of breakthrough insecticides for agriculture.

"John's scientific leadership has been just what Vestaron needed to get us to where we are today," said Jim Schultz of Open Prairie Ventures, a major investor and board director. "We wish John well in his next endeavor."

John Sorenson, Ph.D., will serve as interim President and CEO and continue his current role as Chairman of the Board of Directors. Elin Miller will continue her role as Vice Chairman while the company searches for a new CEO. Vestaron has engaged Kincannon & Reed for the search, which has already begun.

"This is a critical and exciting time for our company with upcoming field trials this summer, which will set the stage for our registration submission. I am thrilled to take the helm," said Dr. Sorenson. Dr. Sorenson has a broad background in plant biotechnology, both in academe and in the private sector. In addition to serving as President of Biotechnology for Syngenta, he also served as President of Syngenta Seed, Inc. and held several positions in the Asgrow Seed Company. Sorenson began his career as Assistant and Associate Professor of Genetics at North Carolina State University.

Vestaron Corporation is a Kalamazoo, Mich.-based company that has been working for the past few years to develop insecticide products that are harmless to humans and other mammals and are environmentally conscious. Using the polypeptides found in spider venom, Vestaron which was formerly known as Venomix, Inc., has reported that its tests are seeing positive results against mosquitoes, caterpillars, flies and cockroaches.

Vestaron Corporation is a portfolio company of Open Prairie Ventures, an Effingham, Illinois- based venture capital firm with offices in Kalamazoo and Southwest Michigan First Life Science Fund.

SOURCE Vestaron Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
2. Every Day is Earth Day for Yulex Corporation
3. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
4. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
5. delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation
6. Techne Corporation Announces Acquisition
7. Ther-Rx Corporation Commits to Take Action Regarding Makena™ Pricing
8. SARcode Corporation to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting
9. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
10. Volcano Corporation Presentation at Roth Capital Conference to be Webcast
11. Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation
Post Your Comments:
(Date:11/24/2015)... -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today announced ... chief executive officer, will present at the 27 th ... New York City . The presentation will be webcast ... 9:30 a.m. EST. and go to ... 15 minutes prior to the presentation to allow for any ...
(Date:11/24/2015)... 24, 2015 According to two new studies, fewer ... is something that many doctors, scientists, and public health experts ... with fewer PSA tests being done, will there be more ... Dr. David Samadi, "Despite the efforts made in regards ... second leading cancer cause of death in men, killing approximately ...
(Date:11/23/2015)... 23, 2015 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its preliminary unaudited financial results for the second quarter ... 30, 2015. --> --> ... Revenues for the second quarter of fiscal 2016 increased ...
(Date:11/23/2015)... GENEVA , November 23, 2015 ... to develop daclatasvir for 112 ... countries   --> --> ... licence for a hepatitis C medicine, signing an agreement with ... proven to help cure multiple genotypes of the HCV virus. ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):